The results showed that only SUMF2 had statistically different expression levels in comorbid patients compared to healthy individuals, while single-cell data showed that SUMF2 was significantly down-regulated in T cells in both the COPD and T2DM groups, which is consistent with all our validation results. The gene discussed is SUMF2; the disease is chronic obstructive pulmonary disease.